Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models. - Johnson, Michael P; Muhlhauser, Mark A; Nisenbaum, Eric S; Simmons, Rosa M A; Forster, Beth M; Knopp, Kelly L; Yang, Lijuan; Morrow, Denise; Li, Dominic L; Kennedy, Jeffrey D; Swanson, Steven; Monn, James A (British Journal of Pharmacology, 2017)